United States · FDA National Drug Code directory

Butalbital, Acetaminophen and Caffeine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
13107-075_bc2de4b3-7c0d-48db-b6e1-ee41bfad08e5
Product NDC
13107-075
Form
CAPSULE
Composition / generic term
Butalbital, Acetaminophen and Caffeine
Labeler
Aurolife Pharma, LLC
Marketing category
ANDA
Marketing start / end (source format)
20170426
Source listing expiry
20261231

Source-listed ingredients

  • BUTALBITAL — 50 mg/1
  • ACETAMINOPHEN — 325 mg/1
  • CAFFEINE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (13107-075-01) · 13107-075-01
  • 500 CAPSULE in 1 BOTTLE (13107-075-05) · 13107-075-05
  • 30 CAPSULE in 1 BOTTLE (13107-075-30) · 13107-075-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Butalbital, Acetaminophen and Caffeine — United States | Molindra Medicines